Page 26 - Editorial Article News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The research establishes the largest open-access proteogenomic dataset to date for the discovery of novel drug targets

The research establishes the largest open-access proteogenomic dataset to date for the discovery of novel drug targets

Target validation is a crucial step in pre-clinical drug discovery workflows that builds confidence on the identification of a genetic target as relevant to a disease. With recent advancements, CRISPR serves as a particularly powerful tool for this process, as it enables researchers to accurately modify genes and determine their function in a variety of experimental systems.

Target validation is a crucial step in pre-clinical drug discovery workflows that builds confidence on the identification of a genetic target as relevant to a disease. With recent advancements, CRISPR serves as a particularly powerful tool for this process, as it enables researchers to accurately modify genes and determine their function in a variety of experimental systems.

With the advent of modern, fully automated instruments, mundane and repetitive manual laboratory tasks could – and should – become a thing of the past. The automation revolution is already well underway in the field of life sciences, as sophisticated robots, miniaturized sample preparation methods, and AI-driven analytical tools are being increasingly integrated into both academic and industrial settings.